ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophrenia

Su, Yi; Yu, Hao; Wang, Zhiren; Liu, Sha; Zhao, Liansheng; Fu, Yingmei; Yang, Yongfeng; Du, Bo; Zhang, Fuquan; Zhang, Xiangrong; Huang, Manli; Hou, Cailan; Huang, Guoping; Su, Zhonghua; Peng, Mao; Yan, Ran; Zhang, Yuyanan; Yan, Hao; Wang, Lifang; Lu, Tianlan; Jia, Fujun; Li, Keqing; Lv, Luxian; Wang, Hongxing; Yu, Shunying; Wang, Qiang; Tan, Yunlong; Xu, Yong; Zhang, Dai; Yue, Weihua广东省人民医院; 北京大学; 上海交通大学; 四川大学; 浙江大学; 6; 1
BJPsych Open2021-6-29DOI: 10.1192/bjo.2021.945
2被引14阅读
引用收藏
分享

摘要

Background Schizophrenia is a severe and complex psychiatric disorder that needs treatment based on extensive experience. Antipsychotic drugs have already become the cornerstone of the treatment for schizophrenia; however, the therapeutic effect is of significant variability among patients, and only around a third of patients with schizophrenia show good efficacy. Meanwhile, drug-induced metabolic syndrome and other side-effects significantly affect treatment adherence and prognosis. Therefore, strategies for drug selection are desperately needed. In this study, we will perform pharmacogenomics research and set up an individualised preferred treatment prediction model. Aims We aim to create a standard clinical cohort, with multidimensional index assessment of antipsychotic treatment for patients with schizophrenia. Method This trial is designed as a randomised clinical trial comparing treatment with different kinds of antipsychotics. A total sample of 2000 patients with schizophrenia will be recruited from in-patient units from five clinical research centres. Using a computer-generated program, the participants will be randomly assigned to four treatment groups: aripiprazole, olanzapine, quetiapine and risperidone. The primary outcomes will be measured as changes in the Positive and Negative Syndrome Scale of schizophrenia, which reflects the efficacy. Secondary outcomes include the measure of side-effects, such as metabolic syndromes. The efficacy evaluation and side-effects assessment will be performed at baseline, 2 weeks, 6 weeks and 3 months. Results This trial will assess the efficacy and side effects of antipsychotics and create a standard clinical cohort with a multi-dimensional index assessment of antipsychotic treatment for schizophrenia patients. Conclusion This study aims to set up an individualized preferred treatment prediction model through the genetic analysis of patients using different kinds of antipsychotics.

学科与关键词

关键词
Antipsychoticsclinical trialschizophreniadrug interactions and side-effectsgenetics
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BJPsych Open
发表日期
2021-06-29
卷期
第 7 卷, 第 4 期
页码
e121
DOI
10.1192/bjo.2021.945
期刊收录
NSL
期刊等级
3区
成果收录
SSCI · SCIE
资助标注
Chinese Ministry of Science and Technology [2016YFC1307000]

作者

  • S

    Su, Yi (第一作者)

    6 · peking univ

  • Y

    Yu, Hao

    6 · peking univ · jining med univ

查看全部 30 位作者收起作者
  • W

    Wang, Zhiren

    beijing huilongguan hosp · peking univ

  • L

    Liu, Sha

    1 · shanxi med univ

  • Z

    Zhao, Liansheng

    mental hlth ctr · sichuan univ

  • F

    Fu, Yingmei

    shanghai jiao tong univ · shanghai mental hlth ctr

  • Y

    Yang, Yongfeng

    2 · xinxiang med univ

  • D

    Du, Bo

    mental hlth ctr · peoples hosp hebei prov

  • Z

    Zhang, Fuquan

    mental hlth ctr · nanjing med univ

  • Z

    Zhang, Xiangrong

    nanjing med univ

  • H

    Huang, Manli

    1 · zhejiang univ

  • H

    Hou, Cailan

    guangdong prov peoples hosp · mental hlth ctr

  • H

    Huang, Guoping

    mental hlth ctr

  • S

    Su, Zhonghua

  • P

    Peng, Mao

    capital med univ

  • Y

    Yan, Ran

    china japan friendship hosp

  • Z

    Zhang, Yuyanan

    peking univ · 6

  • Y

    Yan, Hao

    6 · peking univ

  • W

    Wang, Lifang

    6 · peking univ

  • L

    Lu, Tianlan

    peking univ · 6

  • J

    Jia, Fujun

    guangdong gen hosp · mental hlth ctr

  • L

    Li, Keqing

    mental hlth ctr · peoples hosp hebei prov

  • L

    Lv, Luxian

    2 · xinxiang med univ

  • W

    Wang, Hongxing

    capital med univ

  • Y

    Yu, Shunying

    shanghai jiao tong univ · shanghai mental hlth ctr

  • W

    Wang, Qiang

    mental hlth ctr · sichuan univ

  • T

    Tan, Yunlong

    beijing huilongguan hosp · peking univ

  • X

    Xu, Yong

    1 · shanxi med univ

  • Z

    Zhang, Dai

    peking univ · 6

  • Y

    Yue, Weihua

    peking univ · 6

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417